| Trinidad Pediatric & Adult Therapy Service | |
|
134 W Main St, Suite 12, Trinidad, CO 81082-2604 | |
| (719) 846-4061 | |
| (719) 846-4073 |
| Full Name | Trinidad Pediatric & Adult Therapy Service |
|---|---|
| Type | Facility |
| Speciality | Occupational Therapist |
| Location | 134 W Main St, Trinidad, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275855843 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Trinidad Pediatric & Adult Therapy Service 134 W Main St, Suite 12, Trinidad, CO 81082-2604 Ph: (719) 846-4061 | Trinidad Pediatric & Adult Therapy Service 134 W Main St, Suite 12, Trinidad, CO 81082-2604 Ph: (719) 846-4061 |
News Archive
Vanderbilt researchers evaluating existing treatments for children with autism spectrum disorders found although there were positive results in some studies, there is little information to target the right treatments to specific children.
The incidence of premature babies has been stable or even increased over time. The phenomenon brings with it the possibility of neurological, sensorial, respiratory, cognitive or psychomotor consequences for the child, both in the short and the medium term. These consequences also are a concern to child psychiatrists and psychologists, as it is currently known that the progress of a premature baby and the appearance or otherwise of problems depend largely on the family environment, above all how the mother interacts with her child in the first months of its life.
As President Obama and Congress weigh changes in the nation's health care system they must avoid creating a system where physicians are financially motivated to pressure patients into mandated treatments that conflict with their values and needs, two Beth Israel Deaconess Medical Center physicians warn.
Boehringer Ingelheim announced today that the US Food and Drug Administration (FDA) has approved a new indication for MICARDIS® (telmisartan) for the reduction of the risk of myocardial infarction (heart attack), stroke, or death from cardiovascular (CV) causes in patients 55 years of age or older at high risk of developing major CV events who are unable to take ACE inhibitors. MICARDIS® is the first treatment in its class to be approved for this indication.
Aratana Therapeutics, a newly-formed company focused on the development of innovative therapies for the animal health industry, today announced that it has closed a $20 million Series A financing led by MPM Capital and Avalon Ventures.
› Verified 5 days ago
Mr. Michael J E Fyffe, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2624 Espinoza St, Trinidad, CO 81082 Phone: 419-508-3996 | |
Rexella Sue Day, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 417 N Commercial St, Trinidad, CO 81082 Phone: 719-846-4178 | |
Ms. Sara Jan Ferguson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 409 Benedicta Ave, Trinidad, CO 81082 Phone: 719-846-9291 |